132 related articles for article (PubMed ID: 9059292)
1. Do non-specific minimal signs in a biennial mammographic breast cancer screening programme need further diagnostic assessment?
Maes RM; Dronkers DJ; Hendriks JH; Thijssen MA; Nab HW
Br J Radiol; 1997 Jan; 70():34-38. PubMed ID: 9059292
[TBL] [Abstract][Full Text] [Related]
2. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
Lynge E
APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
[TBL] [Abstract][Full Text] [Related]
3. Screen-detected breast cancer: does presence of minimal signs on prior mammograms predict staging or grading of cancer?
Bansal GJ; Thomas KG
Clin Radiol; 2011 Jul; 66(7):605-8. PubMed ID: 21450283
[TBL] [Abstract][Full Text] [Related]
4. Trends in surgery for screen-detected and interval breast cancers in a national screening programme.
Nederend J; Duijm LE; Louwman MW; Roumen RM; Jansen FH; Voogd AC
Br J Surg; 2014 Jul; 101(8):949-58. PubMed ID: 24828281
[TBL] [Abstract][Full Text] [Related]
5. [Breast carcinoma diagnosed in mammographic screening incidentally. Research on the radiologic signs in prior mammograms].
Marra V; Frigerio A; Di Virgilio MR; Menna S; Burke P
Radiol Med; 1999 Nov; 98(5):342-6. PubMed ID: 10780212
[TBL] [Abstract][Full Text] [Related]
6. Detection of bilateral breast cancer at biennial screening mammography in the Netherlands: a population-based study.
Setz-Pels W; Duijm LE; Groenewoud JH; Voogd AC; Jansen FH; Hooijen MJ; Louwman MW
Radiology; 2011 Aug; 260(2):357-63. PubMed ID: 21474705
[TBL] [Abstract][Full Text] [Related]
7. Interval carcinomas in the Malmö Mammographic Screening Trial: radiographic appearance and prognostic considerations.
Ikeda DM; Andersson I; Wattsgård C; Janzon L; Linell F
AJR Am J Roentgenol; 1992 Aug; 159(2):287-94. PubMed ID: 1632342
[TBL] [Abstract][Full Text] [Related]
8. Screening mammography: value in women 35-39 years old.
Liberman L; Dershaw DD; Deutch BM; Thaler HT; Lippin BS
AJR Am J Roentgenol; 1993 Jul; 161(1):53-6. PubMed ID: 8517320
[TBL] [Abstract][Full Text] [Related]
9. Impact of changing from annual to biennial mammographic screening on breast cancer outcomes in women aged 50-79 in British Columbia.
Coldman AJ; Phillips N; Olivotto IA; Gordon P; Warren L; Kan L
J Med Screen; 2008; 15(4):182-7. PubMed ID: 19106258
[TBL] [Abstract][Full Text] [Related]
10. The National Breast and Cervical Cancer Early Detection Program: report on the first 4 years of mammography provided to medically underserved women.
May DS; Lee NC; Nadel MR; Henson RM; Miller DS
AJR Am J Roentgenol; 1998 Jan; 170(1):97-104. PubMed ID: 9423608
[TBL] [Abstract][Full Text] [Related]
11. The current detectability of breast cancer in a mammographic screening program. A review of the previous mammograms of interval and screen-detected cancers.
van Dijck JA; Verbeek AL; Hendriks JH; Holland R
Cancer; 1993 Sep; 72(6):1933-8. PubMed ID: 8364871
[TBL] [Abstract][Full Text] [Related]
12. The detectability of breast cancer by screening mammography.
Ciatto S; Rosselli Del Turco M; Zappa M
Br J Cancer; 1995 Feb; 71(2):337-9. PubMed ID: 7841050
[TBL] [Abstract][Full Text] [Related]
13. Tubular carcinoma of the breast: mode of presentation, mammographic appearance, and frequency of nodal metastases.
Elson BC; Helvie MA; Frank TS; Wilson TE; Adler DD
AJR Am J Roentgenol; 1993 Dec; 161(6):1173-6. PubMed ID: 8249721
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the contralateral breast in patients with ipsilateral breast carcinoma: the role of mammography.
Muttarak M; Pojchamarnwiputh S; Padungchaichote W; Chaiwun B
Singapore Med J; 2002 May; 43(5):229-33. PubMed ID: 12188073
[TBL] [Abstract][Full Text] [Related]
15. Patterns of axillary lymphadenopathy demonstrated by mammography: implications for the asymptomatic woman in a breast screening programme.
Hunter JV; Hunter GJ; Tucker AK
Clin Radiol; 1987 Sep; 38(5):515-7. PubMed ID: 3665348
[TBL] [Abstract][Full Text] [Related]
16. The Gothenburg breast screening trial: first results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization.
Bjurstam N; Björneld L; Duffy SW; Smith TC; Cahlin E; Eriksson O; Hafström LO; Lingaas H; Mattsson J; Persson S; Rudenstam CM; Säve-Söderbergh J
Cancer; 1997 Dec; 80(11):2091-9. PubMed ID: 9392331
[TBL] [Abstract][Full Text] [Related]
17. Mammographic screening after the age of 65 years: early outcomes in the Nijmegen programme.
van Dijck J; Verbeek A; Hendriks J; Holland R; Mravunac M
Br J Cancer; 1996 Dec; 74(11):1838-42. PubMed ID: 8956803
[TBL] [Abstract][Full Text] [Related]
18. Quality assessment of the mammographic screening programme in the Azienda Sanitaria locale Provincia Milano 1 -- analysis of interval cancers and discussion of possible causes of diagnostic error.
Burani R; Caimi F; Maggioni C; Marinoni G; Pellizzoni R; Pirola ME; Villa R; Ciatto S
Radiol Med; 2005 Mar; 109(3):260-7. PubMed ID: 15775895
[TBL] [Abstract][Full Text] [Related]
19. Results of intermediate measures from a population-based, randomized trial of mammographic screening prevalence and detection of breast carcinoma among Asian women: the Singapore Breast Screening Project.
Ng EH; Ng FC; Tan PH; Low SC; Chiang G; Tan KP; Seow A; Emmanuel S; Tan CH; Ho GH; Ng LT; Wilde CC
Cancer; 1998 Apr; 82(8):1521-8. PubMed ID: 9554530
[TBL] [Abstract][Full Text] [Related]
20. Influence of mammographic parenchymal pattern in screening-detected and interval invasive breast cancers on pathologic features, mammographic features, and patient survival.
Porter GJ; Evans AJ; Cornford EJ; Burrell HC; James JJ; Lee AH; Chakrabarti J
AJR Am J Roentgenol; 2007 Mar; 188(3):676-83. PubMed ID: 17312053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
